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Human serum albumin (HSA) is the most abundant plasma protein, with described 
ligand-binding and transport properties, antioxidant functions, and enzymatic activities. 
Commercial HSA is indicated for re-establishing and maintaining circulatory volume 
in situations resulting from traumatic shock, surgery or blood loss. [1] HSA is also 
used in extracorporeal liver support devices that performs blood dialysis against this 
protein. [2] Therapeutic HSA accounts for 14 % of the global market volume for plasma 
products.
Although therapeutic HSA has been used for more than 50 years, the composition 
of the commercial product remains unclear. Characterization of its composition is, 
however, crucial in order to understand its therapeutic effects and adverse reactions, as 
well as the mechanisms involved in different albumin therapies.
Here, we present the results from an exhaustive analysis of therapeutic human serum 
albumin composition using proteomic approaches. Low abundant proteins and peptides 
in these samples were concentrated using a strong anion exchange (SAX) resin (ion 
exchanger MARS, Gambro, Lund, Sweden). The absorbed material was eluted with 
stepwise gradient of ammonium trifluoroacetate and the resulting fraction analyzed by 
MDLC-MS/MS using an LTQ ion trap.
Besides albumin, a total of 1467 peptides corresponding to 102 proteins were 
identified with a false discovery rate of 1%. Relative to the human plasma proteome 
(www.plasmaproteomedatabase.org), the collection of proteins identified was 
apparently enriched on proteins involved in immunity and defense and transport (www.
panther.org).
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